Navigation Links
Medicago initiates work on Swine Flu strain
Date:4/28/2009

QUEBEC CITY, April 28 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has received a genetic sequence of the new strain of influenza A (H1N1) that has recently been identified in USA and Mexico, and has commenced laboratory work with its VLP vaccine technology to produce material for testing. According to the World Health Organization ("WHO"), a genetic analysis shows this new flu strain is a never-before-seen mixture of swine, human and avian viruses and has the potential of becoming a pandemic. The Company has already expressed VLPs of the following pandemic strains in plants: Singapore (H2N2), Anhui (H5N1), Vietnam (H5N1), Hong Kong (H6N1 and H9N2), Equine/Prague (H7N7), and of the seasonal strains New Caledonia (H1N1), Solomon Island (H1N1) and Brisbane (H1N1). Medicago is keeping health authorities informed on its work.

Medicago's H5N1 pandemic VLP vaccine has shown to be immunogenic at doses as low as 5 micrograms in preclinical studies and provided 100% cross-protection to different strains of the H5N1 virus in an animal model. The Company's proprietary plant-based manufacturing technology could deliver a vaccine, just one month after the identification of the genetic sequence from an emerging pandemic strain. This vaccine would then be tested in animals and humans and reviewed by Health Canada before it is produced on a commercial scale. Medicago recently had a pre-Clinical Trial Application ("CTA") meeting with Health Canada's Biologics and Genetic Therapies Directorate ("BGTD"). Based on the outcome of the meeting, the Company is finalising pre-clinical studies and preparing to move ahead with the submission of a CTA for its lead H5N1 pandemic VLP vaccine and with final approval will initiate a Phase I clinical trial in the third quarter of 2009.'/>"/>

SOURCE Medicago Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
3. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
4. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
5. Nventa Initiates HspE7 Phase 1 Cervical Dysplasia Trial
6. Cytochroma initiates Phase I/II clinical trial of CTAP101 Capsules for vitamin D insufficiency in chronic kidney disease
7. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
8. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
9. Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy
10. Conatus Pharmaceuticals Initiates a Phase 2 Clinical Trial for the Treatment of Hepatitis
11. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or ... financial results for the six months ended June ... in Canadian dollars and presented under International Financial ... Highlights , Announced top-line results related ... endpoint for subjects enrolled in the Phase 2 ...
(Date:8/29/2014)... Antonio, TX (PRWEB) August 29, 2014 ... and ISO 13485:2003 certified, GAMP® 5 compliant imaging ... awarded an international Phase II clinical trial to ... lymphoma. , Throughout this trial, Intrinsic Imaging will ... not limited to, protocol and charter development, site ...
(Date:8/28/2014)... LAFAYETTE, Ind. A new research platform ... properties of tiny structures undergoing stress and ... to improve designs for microelectronics and batteries., ... reveals information about how heating and the ... mechanical properties. Researchers have discussed the merits ...
(Date:8/28/2014)... ATLANTA , Aug. 28, 2014   SunTrust ... of three industry veterans to its equity research ... "Our ongoing expansion in equity research demonstrates ... with unique insights to enhance their investment decision ... Equities at STRH.  "We continue to make significant ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3
... May 28 Clontech Laboratories, Inc., a wholly-owned subsidiary ... 1, 2009) release of the Xfect(TM) and Xfect(TM) Stem ... biodegradable nanoparticles that permit superior transfection efficiency of plasmid ... transfections can be carried out entirely in the presence ...
... efficacy of SpyGlass System for diagnostic and therapeutic ... Boston Scientific Corporation (NYSE: BSX ) ... data analyses involving the SpyGlass(R) Direct Visualization System ... which runs from May 30 to June 4 ...
... California, and AMSTERDAM, May 28 ,Agendia, a world ... support of Genentech,s Citizen,s Petition. Filed on December ... vitro diagnostic,tests be held to one set of ... 2009, Agendia formally submitted a letter of support ...
Cached Biology Technology:Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents 2Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 2Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 3Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 4Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 5Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 6Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards 2
(Date:8/31/2014)... go after each other. But when viruses invade bacteria, ... Sometimes viruses actually carry helpful genes that a bacterium ... attack its own hosts. , Scientists have assumed the ... anything it recognized as invading viral genes. However, new ... variety of the bacterial immune system known as the ...
(Date:8/29/2014)... have made some surprising discoveries about the body,s ... virus (SIV), the team found that specialized cells ... responders to viral invasion and are the source ... interleukin-1 beta (IL-1β). , Though aimed at ... the gut epithelium that provides a barrier to ...
(Date:8/29/2014)... the type and number of connections in transcription factor ... robustness in a study published in PLOS Computational ... the assortativity signature contributes to a network,s resilience against ... the out-out assortativity of TFN models has a greater ... three types of assortativity," said Dov A. Pechenick, PhD, ...
Breaking Biology News(10 mins):Discovery reveals how bacteria distinguish harmful vs. helpful viruses 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 3The early cost of HIV 2Assortativity signatures of transcription factor networks contribute to robustness 2
... Researchers at the University of Georgia have developed ... ethanol from pretreated pine -- one of the most ... Their research could help biofuels replace gasoline as a ... from woody biomass such as pine, but it is ...
... Human domestication of soybeans is thought to have first occurred ... suggest that cultures in even earlier times and in other ... charred soybean samples from 22 sites in northern China, Japan ... flooring and dumping pits -- with 180 modern charred and ...
... people who initially survive a heart attack, a significant cause ... -- literally, bursting of the heart wall. A ... protein as the key player in the biochemical cascade that ... an Advance Online Publication (AOP) of the journal Nature ...
Cached Biology News:UGA researchers develop 'super' yeast that turns pine into ethanol 2Soybean adoption came early by many cultures, archaeologists say 2Study explains how heart attack can lead to heart rupture 2Study explains how heart attack can lead to heart rupture 3
The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
... Kit is designed for fast and easy ... cells and tissues. The bead beating technology ... isolation procedures such as CTAB, phenol, or ... precipitation is not necessary - purified DNA ...
... ApopTag Red In Situ Apoptosis Detection ... the indirect TUNEL method, utilizing an ... The kit provides indirect immunofluorescence staining ... using either fluorescence microscopy or flow ...
... The BioGenex VISION Sytem is ... that comes with proprietary digital imaging ... for digital image acquisition, analysis, archving/retrieval ... is a state-of-the-art digital imaging system ...
Biology Products: